21
Participants
Start Date
January 19, 2017
Primary Completion Date
June 11, 2025
Study Completion Date
June 11, 2025
Doxercalciferol (GZ427397)
"Pharmaceutical form: capsule~Route of administration: oral"
Calcitriol
"Pharmaceutical form: capsule~Route of administration: oral"
Mount Sinai Medical Center Site Number : 8400007, New York
Cohen Children's Medical Center of NY Site Number : 8400017, New Hyde Park
Children's Hospital of Pittsburgh Site Number : 8400028, Pittsburgh
Virginia Commonwealth University Site Number : 8400009, Richmond
East Carolina University, Brody School of Medicine Site Number : 8400025, Greenville
Greenville Hospital System Site Number : 8400027, Greenville
University of Miami Site Number : 8400006, Miami
Nicklaus Children's Hospital Site Number : 8400008, Miami
Children's Hospital Of Alabama Site Number : 8400022, Birmingham
Vanderbilt University Medical Center Site Number : 8400024, Nashville
Marshfield Clinic Site Number : 8400001, Marshfield
University of Minnesota Site Number : 8400014, Minneapolis
Rush University Medical Center Site Number : 8400020, Chicago
Texas Children's Hospital Site Number : 8400013, Houston
University of Utah Site Number : 8400026, Salt Lake City
Cedars Sinai Medical Center Site Number : 8400033, Los Angeles
UC DAVIS Medical Center Site Number : 8400005, Sacramento
Yale University School of Medicine Site Number : 8400029, New Haven
Hackensack University Site Number : 8400010, Hackensack
Goryeb Children's Hospital Site Number : 8400016, Morristown
Duke University Medical Center Site Number : 8400034, Durham
Investigational Site Number : 1520003, Santiago
Investigational Site Number : 1520004, Concepción
Lead Sponsor
Sanofi
INDUSTRY